The 7 analysts offering 12-month price forecasts for Albireo Pharma Inc have a median target of 73.00, with a high estimate of 81.00 and a low estimate of 65.00. The median estimate represents a +103.91% increase from the last price of 35.80.
The current consensus among 8 polled investment analysts is to Buy stock in Albireo Pharma Inc. This rating has held steady since July, when it was unchanged from a Buy rating.Move your mouse over past months for detail
Earnings and Sales Forecasts
Earnings per Share -$1.80
Reporting Date May 13
Earnings per Share
Move your mouse over a quarter or year to see how estimates have changed over time.